Rho recently conducted a flu vaccine study, and our team enrolled 360+ patients in 3 days at 4 clinical sites. The study had 96.9% retention through day 50 of the study and 90.4% of participants completed their final visit on day 345 of the study.
Our study team built and maintains excellent relationships with the clinical sites that participated in this study.